A
VERA icon

AlphaQuest’s Vera Therapeutics VERA Stock Holding History

AlphaQuest’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,605
Closed -$81.3K – 2014
2025
Q4 		$81.3K Sell
1,605
-3,609
-69% -$128K ﹤0.01% 1815
2025
Q3 		$152K Buy
5,214
+4,200
+414% +$97.1K 0.01% 1542
2025
Q2 		$23.9K Sell
1,014
-2,993
-75% -$67.3K ﹤0.01% 1769
2025
Q1 		$96.2K Buy
4,007
+3,213
+405% +$103K 0.01% 1313
2024
Q4 		$33.6K Buy
+794
New +$35.2K ﹤0.01% 1361
2024
Q3 		– Sell
-125
Closed -$4.52K – 1999
2024
Q2 		$4.52K Sell
125
-1,930
-94% -$76.6K ﹤0.01% 1342
2024
Q1 		$88.6K Buy
2,055
+722
+54% +$25.7K 0.02% 841
2023
Q4 		$20.5K Buy
+1,333
New +$16.9K ﹤0.01% 963

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AlphaQuest's VERA Position: Q1 2026 in Review

AlphaQuest sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 1,605 shares — an estimated $81.3K sold.

AlphaQuest first reported a position in VERA in Q4 2023 and held it in 8 quarters. The position peaked at $152K in Q3 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • AlphaQuest reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,605 Vera Therapeutics shares in Q1 2026, an estimated $81.3K.
  • AlphaQuest first reported a position in Vera Therapeutics in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Vera Therapeutics position peaked at $152K in Q3 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.